SC
BLFS icon

Stephens Consulting’s BioLife Solutions BLFS Stock Holding History

Stephens Consulting’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-89
Closed -$2.27K – 485
2025
Q3 		$2.27K Buy
+89
New +$2.11K ﹤0.01% 319
2025
Q2 		– Sell
-15
Closed -$343 – 1306
2025
Q1 		$343 Buy
+15
New +$395 ﹤0.01% 1374

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Stephens Consulting's BLFS Position: Q4 2025 in Review

Stephens Consulting sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 89 shares — an estimated $2.27K sold.

Stephens Consulting first reported a position in BLFS in Q1 2025 and held it in 2 quarters. The position peaked at $2.27K in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Stephens Consulting reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Stephens Consulting sold 89 BioLife Solutions shares in Q4 2025, an estimated $2.27K.
  • Stephens Consulting first reported a position in BioLife Solutions in Q1 2025 and held it in 2 quarters.
  • Stephens Consulting's BioLife Solutions position peaked at $2.27K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.